Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Four-period, Crossover Study in Two Panels of Healthy Adult Subjects to Assess the Relative Bioavailability, Food Effect, and Dose-dependence of Single-dose Immediate-release and Single-dose Dispersible Formulations of Pretomanid
Conditions
Interventions
Pretomanid
Locations
1
United States
Worldwide Clinical Trials Early Phase Services, LLC
San Antonio, Texas, United States
Start Date
January 14, 2020
Primary Completion Date
February 28, 2020
Completion Date
February 28, 2020
Last Updated
July 24, 2024
NCT03822156
NCT03000517
NCT01600963
Lead Sponsor
Global Alliance for TB Drug Development
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions